FDA Inspection 905182 — Attix Pharmaceuticals Inc.

Attix Pharmaceuticals Inc. — FEI 3008197162

The FDA completed an inspection of Attix Pharmaceuticals Inc. on Nov 14, 2014 in Toronto. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Nov 14, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Toronto (Canada)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.